Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Hereditary Breast and Ovarian Cancer Syndrome Background Information • 10% of ovarian cancer is genetic • 5% of breast cancer is genetic • BRCA 1 and 2 BRCA • Incidence is 1 out of 300-800 in the general population • BRCA 1 pos risk of ovarian cancer is 39-46% and risk of breast cancer is 65-75% • BRCA 2 pos risk of ovarian cancer is 12-20% and risk of breast cancer is 65-75% • BRCA pos ovarian cancer is mainly high grade serous or endometroid 20-25% Chance of BRCA pos • PH of both breast and ovarian cancer • PH of ovarian cancer and 1 close relative with ovarian cancer or premenopausal breast cancer • PH of breast cancer <50 and close relative with ovarian cancer or male breast cancer any age • FH of close relative that is BRCA pos 5-10% Chance of BRCA • PH breast cancer <40 years • PH of high grade serous ovarian cancer any age • PH of bilateral breast cancer • PH of breast cancer <50 yrs and close relative with breast cancer <50 yrs • PH of breast cancer any age and 2 close relatives with breast cancer any age What to do if BRCA pos? • Ca 125 and pelvic ultrasound beginning age 30-35 • Use birth control pills for contraception • Prophylactic BSO – Ovarian cancer reduction 90% – Breast cancer reduction 40-70% • Prophylactic mastectomy – 90-95% reduction What to do if BRCA pos? • Breast MRI annually at age 25 • Tamoxifen – Only helps BRCA 2 with reduction of 60% Salpingectomy for Prevention of Ovarian Cancer in Low Risk Populations Should the fallopian tube be removed and leave the ovaries? • Concern regarding reduced ovarian function when you remove the tube • Preserving the ovaries would benefit woman when it comes to bone health and cardiovascular disease • Total salpingectomy is not reversible Vulvodynia Formerly known as Vestibulitis or Vestibular Adenitis Clinical Triad • Entrance dysparunia • Recurrent bouts of vaginitis • Chronic UTI episodes or symptoms Physical Exam • Initial inspection to look for dermatologic causes of pain • Map tender areas with a Q-tip • Speculum exam to look for atrophy or vaginitis • Single digit exam to isolate areas of tenderness • Bimanual exam to determine if there is cervical, uterine, or adenexal tenderness Treatment • • • • • • • Avoid vulvar irritants Mid potency corticosteroid ointment Topical lidocaine 5% ointment Tricyclic antidepressants Gabapentin Topical estrogen Pelvic floor relaxation